Related Experiment Videos
Left ventricular hypertrophy: an independent risk factor
1Department of Internal Medicine, Ochsner Clinic, New Orleans, LA 70121.
Insights
Left ventricular hypertrophy (LVH) significantly increases cardiovascular risks. Reducing LVH through antihypertensive therapy shows promise, but further studies are needed to confirm clinical benefits.
Area of Science:
- Cardiology
- Internal Medicine
- Pathophysiology
Background:
- Left ventricular hypertrophy (LVH) is a marked increase in left ventricle muscle mass.
- LVH is a potent predictor of cardiovascular morbidity and mortality.
- It elevates risks for myocardial infarction, heart failure, and sudden death six- to eightfold.
Purpose of the Study:
- To review the pathophysiology and clinical implications of LVH.
- To discuss the impact of LVH on cardiac function and oxygen demand.
- To explore the potential of antihypertensive therapy in managing LVH.
Main Methods:
- Review of existing literature on LVH.
- Analysis of factors contributing to increased hemodynamic burden.
- Evaluation of the effects of antihypertensive treatments.
Main Results:
- LVH impairs coronary reserve, increases cardiac oxygen needs, and affects ventricular filling and contractility.
- Conditions like hypertension, obesity, and valvular heart disease contribute to LVH.
- Antihypertensive therapy can potentially reduce LVH and its consequences.
Conclusions:
- LVH poses a significant threat to cardiovascular health.
- Therapeutic interventions targeting blood pressure may mitigate LVH.
- Further epidemiological research is essential to validate the clinical advantages of LVH reduction.
Abstract:
Left ventricular hypertrophy (LVH), an increase in the muscle mass of the left ventricle, has been identified as a powerful risk factor for future cardiovascular morbidity and mortality. The risk of acute myocardial infarction, congestive heart failure, sudden death, and other cardiovascular events increases six- to eightfold with the presence of LVH. The increase in myocardial mass lowers coronary reserve and enhances cardiac oxygen requirements, gives rise to ventricular ectopy, and impairs left ventricular filling and contractility. Hypertension, obesity, advanced age, valvular heart disease, and other disorders that cause an increase in the hemodynamic burden can lead to LVH. Left ventricular hypertrophy and its sequelae can be reduced by specific antihypertensive therapy but, despite these promising findings, future epidemiological studies are necessary to document the clinical benefits of a reduction of LVH.